Violation Tracker Parent Company Summary

Parent Company Name: 
GlaxoSmithKline
Ownership Structure: 
publicly traded (ticker symbol GSK)
Headquartered in: 
Britain
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$4,367,612,127
Number of records: 
32
Top 10 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$3,004,361,8604
drug or medical equipment safety violation$880,750,0004
False Claims Act and related$329,002,28511
kickbacks and bribery$125,000,0002
price-fixing or anti-competitive practices$27,500,0003
environmental violation$585,7096
wage and hour violation$352,7731
aviation safety violation$59,5001
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

BLOCK DRUG; GLAXO SMITH KLINE; GLAXOSMITH KLINE; GlaxoSmithKline; GLAXOSMITHKLINE COLLEGEVILLE FAC; GLAXOSMITHKLINE PLC; GLAXOSMITHKLINE VACCINES; SB Pharmco Puerto Rico Inc.; SmithKline Beecham Corp.

Links: 

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

For a summary of this company's federal contracts, see its page on Fedspending.

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
GlaxoSmithKline LLC off-label or unapproved promotion of medical products 2012 FDA $3,000,000,000
SB Pharmco Puerto Rico Inc. drug or medical equipment safety violation 2010 FDA $750,000,000
GlaxoSmithKline off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $477,792,391
SB Pharmco Puerto Rico Inc. drug or medical equipment safety violation 2010 MULTI-AG (*) $163,560,000
GlaxoSmithKline False Claims Act and related 2005 DOJ_CIVIL $150,000,000
GlaxoSmithKline, LLC kickbacks and bribery 2014 MULTI-AG $105,000,000
GlaxoSmithKline LLC drug or medical equipment safety violation 2012 MULTI-AG $90,000,000
GlaxoSmithKline False Claims Act and related 2006 MULTI-AG $70,000,000
SmithKline Beecham False Claims Act and related 2003 DOJ_CIVIL $47,000,000
GlaxoSmithKline, LLC drug or medical equipment safety violation 2011 MULTI-AG $40,750,000
GlaxoSmithKline False Claims Act and related 2003 MULTI-AG $40,000,000
GlaxoSmithKline plc kickbacks and bribery 2016 SEC $20,000,000
GlaxoSmithKline price-fixing or anti-competitive practices 2006 MULTI-AG $14,000,000
GlaxoSmithKline False Claims Act and related 2005 MULTI-AG (*) $10,000,000
GlaxoSmithKline False Claims Act and related 2012 LA-AG $10,000,000
SmithKline Beecham Corp. price-fixing or anti-competitive practices 2005 MULTI-AG $10,000,000
GlaxoSmithKline False Claims Act and related 2011 KS-AG $4,250,000
GlaxoSmithKline off-label or unapproved promotion of medical products 2010 KY-AG $3,700,000
GlaxoSmithKline price-fixing or anti-competitive practices 2006 MULTI-AG $3,500,000
GlaxoSmithKline LLC False Claims Act and related 2010 HI-AG $3,333,333
GlaxoSmithKline False Claims Act and related 2012 ID-AG $2,600,000
SmithKline Beecham Corp. False Claims Act and related 2007 TX-AG $1,400,000
GlaxoSmithKline off-label or unapproved promotion of medical products 2009 KY-AG $661,860
GlaxoSmithKline False Claims Act and related 2006 GA-AG $418,952
Block Drug Company Incorporated wage and hour violation 2011 WHD $352,773
GlaxoSmithKline LLC environmental violation 2014 EPA $317,550
GLAXOSMITHKLINE, LLC environmental violation 2014 EPA (*) $317,550
GlaxoSmithKline Vaccines environmental violation 2014 EPA $172,900
GLAXOSMITHKLINE VACCINES environmental violation 2014 EPA (*) $172,900
GLAXOSMITH KLINE environmental violation 2014 EPA $90,000
GLAXO SMITH KLINE aviation safety violation 2014 FAA $59,500
GLAXOSMITHKLINE COLLEGEVILLE FAC environmental violation 2017 EPA $5,259
Download results as CSV or XML